Clinicolaboratory study of 25 fatal cases of COVID-19 in Wuhan

Intensive Care Med. 2020 Jun;46(6):1117-1120. doi: 10.1007/s00134-020-06023-4. Epub 2020 Apr 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Betacoronavirus / immunology
  • Betacoronavirus / pathogenicity*
  • Biomarkers / blood
  • C-Reactive Protein / metabolism
  • COVID-19
  • Cause of Death
  • China / epidemiology
  • Comorbidity
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / immunology
  • Coronavirus Infections / mortality
  • Coronavirus Infections / physiopathology*
  • Critical Care
  • Cytokine Release Syndrome / mortality
  • Cytokine Release Syndrome / physiopathology*
  • Cytokine Release Syndrome / virology
  • Female
  • Fibrin Fibrinogen Degradation Products / metabolism
  • Humans
  • Interleukin-6 / blood
  • Male
  • Middle Aged
  • Multiple Organ Failure / mortality
  • Multiple Organ Failure / physiopathology*
  • Multiple Organ Failure / virology
  • Pandemics
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / immunology
  • Pneumonia, Viral / mortality
  • Pneumonia, Viral / physiopathology*
  • Retrospective Studies
  • SARS-CoV-2
  • Sex Factors

Substances

  • Antibodies, Monoclonal, Humanized
  • Biomarkers
  • Fibrin Fibrinogen Degradation Products
  • Interleukin-6
  • fibrin fragment D
  • C-Reactive Protein
  • tocilizumab